Clinical Trial Update: Effect of resVida on Liver Fat Content [NA]

View source ↗

Summary

This completed clinical trial assessed whether resVida reduces liver fat content in individuals with elevated liver fat and insulin resistance.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance
• Nonalcoholic Fatty Liver Disease

Drugs mentioned

• resVida

Snippet

Sponsor: University Hospital Tuebingen | Conditions: Elevated Liver Fat Content and Insulin Resistance | NA | Status: COMPLETED